ClinicalTrials.gov
public full text
Public Domain
Clinical Study of 68Ga Labeled HER2 Affibody Analogues
The purpose of this study is to assess the dosimetric properties of the positron emission tomography (PET) imaging probe 68Ga labeled HER2 Affibody analogues and preliminarily evaluate its diagnosis value in patients with breast or gastric tumors.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- 68Ga-HER2 Affibody PET/CT Imaging for HER2-Positive Cancer Patients#1009488
- 99mTc Labelled Affibody SPECT/CT Imaging for Breast Cancer HER2 Characterization#885680
- 68Ga-Citrate PET of Healthy Volunteers#918975
- Gallium-68 DOTATOC for Management of Neuroendocrine Tumors#1088311
- Fecal Screening Assay for Taiwanese Population#1140762
Record · ID 969391
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive